Jin Jen


Dr. Jen obtained her Ph.D. from University of California, San Francisco and completed her postdoctoral training at the Johns Hopkins University, School of Medicine. Dr. Jen joined the faculty at Johns Hopkins University in 1996 and then a principal investigator at NCI prior to joining the Mayo Clinic in 2008 where she served as the Director of the Mayo Gene Expression Analysis Core. Since 2015, Dr. Jen became the Co-Director for the Genome Analysis Core, Medical Genome Facility at the Center for Individualized Medicine where she leads the development and implementation of whole transcriptase sequencing technologies for research and clinical applications. Dr. Jen is an associate professor at the Department of Laboratory Medicine and Pathology and an expert in the molecular genetics of non-small cell lung cancer. Her current research focuses on using next-generation sequencing (NGS) and liquid biopsy approaches to identify genetic markers for optimized treatment stratification and disease monitoring in cancer.

Dr. Jen has co-authored many peer-reviewed publications and is an inventor to five published patents. She is an Associate Editor for Clinical Cancer Research and has served on study sessions for NIH and the American Cancer Society. Dr. Jen’s research has been funded by grants from the National Cancer Institute, National Foundation for Cancer Research, and the Mayo Clinic – University of Minnesota Partnership.

Research Interests:

Her research interest, mainly focuses on to identify molecular changes associated with lung cancer and to develop effective strategies that utilize tumor associated genetic changes to improve the diagnosis, prognosis and treatment of this deadly disease.

Open Access Journals

Recently Released Issues

Social Network

Loading ....
Loading ....
Loading ....

Abstracting and Indexing

Boffin Access use Crossref Similarity Check for averting plagiarism


Boffin Access Limited is committed to maintaining the integrity of the scholarly record to researchers. Therefore violation of professional ethical codes may lead to retract articles. Article(s) may be retracted if it is found to have serious flaws, reported misconduct research, constitute copyright infringement and plagiarism.
To help avoid the incorrect or misleading publications, please drop your message to

Send Information

Subscribe to our Newsletter

Enter your e-mail address to stay informed about published articles, issue releases and latest updates on journal activities.


We openly welcome feedback and constructive criticism. Your compliments, concerns and suggestions regarding our services will prove enormously helpful in making them even better.

Do you have an idea or suggestion that can influence the Open Access community? Send an email to: support@boffinaccess.org